Article Text

Download PDFPDF
gp120 modulates the biology of human hepatic stellate cells: a link between HIV infection and liver fibrogenesis
  1. Raffaele Bruno1,
  2. Sara Galastri2,
  3. Paolo Sacchi1,
  4. Serena Cima1,
  5. Alessandra Caligiuri2,
  6. Raffaella DeFranco2,
  7. Stefano Milani3,4,
  8. Sandra Gessani5,
  9. Laura Fantuzzi5,
  10. Francesco Liotta2,
  11. Francesca Frosali2,
  12. Giorgio Antonucci6,
  13. Massimo Pinzani2,4,
  14. Fabio Marra2,4
  1. 1Division of Infectious and Tropical Diseases, University of Pavia-Foundation IRCCS San Matteo Hospital, Pavia, Italy
  2. 2Dipartimento di Medicina Interna, University of Florence, Florence, Italy
  3. 3Dipartimento di Fisiopatologia Clinica, University of Florence, Florence, Italy
  4. 4Center for Research, Transfer and Higher Education DenoTHE, University of Florence, Florence, Italy
  5. 5Istituto Superiore di Sanitá, Rome, Italy
  6. 6INMI L. Spallanzani-IRCCS, Rome, Italy
  1. Correspondence to Professor Fabio Marra, Dipartimento di Medicina Interna, University of Florence, Viale Morgagni 85, I-50134 Florence, Italy; f.marra{at}


Objective In patients with hepatitis C virus (HCV)/HIV co-infection, a faster progression of liver fibrosis to cirrhosis has been reported. In this study, an investigation was carried out to determine whether gp120, an HIV envelope protein, modulates the biology of human hepatic stellate cells (HSCs), key cell types in the pathogenesis of fibrosis.

Methods Myofibroblastic HSCs were isolated from normal human liver tissue. Gene expression was measured by real-time PCR. Cell migration was assessed in Boyden chambers. Intracellular signalling pathways were evaluated using phosphorylation-specific antibodies or by transfection of a reporter plasmid.

Results Transcripts for the chemokine receptors CCR5 and CXCR4, which bind gp120, were detectable in human HSCs. Upon exposure to M-tropic recombinant gp120, which binds CCR5, a significant increase in HSC chemotaxis was observed (1.6±0.3-fold, p=0.03). The effects of gp120 were prevented by protein inactivation. gp120 also resulted in a significant increase in secretion (1.5±0.3-fold, p=0.03) and gene expression (1.47±0.13-fold, p=0.02) of the proinflammatory chemokine monocyte chemoattractant protein-1, and in increased gene expression of tissue inhibitor of metalloprotease-1 and interleukin-6 (2.03±0.57-fold, p=0.02). gp120-induced migration required Akt activation. gp120 also induced activation of nuclear factor-κB (NF-κB) and p38MAPK. Preincubation of HSCs with TAK779, a CCR5 receptor antagonist, prevented gp120-mediated chemotaxis and monocyte chemoattractant protein-1 secretion. Expression of CCR5 was detectable in areas of inflammation and fibrogenesis in liver biopsies of patients with HCV/HIV co-infection.

Conclusions This study shows that HIV gp120 modulates different aspects of HSC biology, including directional cell movement and expression of proinflammatory cytokines. These results identify a direct pathway possibly linking HIV infection with liver fibrogenesis via envelope proteins.

  • Chemokines
  • CCR5
  • hepatic stellate cells
  • HIV
  • liver fibrosis
  • chemotaxis
  • hepatic fibrosis

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • RB and SG (the first two authors) contributed equally to this work.

  • Funding Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; University of Florence, Italy; Roche, Italy.

  • Competing interests Declared (the declaration can be viewed on the Gut website at

  • Ethics approval This study was conducted with the approval of the IRCCS San Matteo Hospital, Pavia, and of the INMI L. Spallanzani-IRCCS, Rome, Italy

  • Provenance and peer review Not commissioned; externally peer reviewed.

Linked Articles